Overview
Jeffrey Crane is a Hematologist Oncology provider practicing medicine in Raleigh, North Carolina.
Dr. Crane is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Febrile Neutropenia, Agranulocytosis, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Crawford is board certified in American Board Of Internal Med, Hematology/Oncology , American Board Of Internal Med, Internal Medicine , and American Board Of Internal Med, Medical Oncology.
Duke Cancer Center
Diane Reidy is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Reidy is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
Duke Cancer Center
Michael Morse is a Hematologist Oncology specialist and an Oncologist practicing medicine in Durham, North Carolina. He has been practicing medicine for over 36 years. Dr. Morse is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Appendix Cancer, and Liver Embolization. Dr. Morse is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.
Frequently Asked Questions about Dr. Jeffrey M. Crane
How do I make an appointment with Dr. Jeffrey M. Crane?
You can book an appointment with Dr. Jeffrey M. Crane by calling their office at 919-784-6818. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jeffrey M. Crane a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey M. Crane is classified as an Advanced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jeffrey M. Crane specialize in?
While Dr. Jeffrey M. Crane is a Hematology Oncology, they have specific expertise in Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Jeffrey M. Crane participate in research or clinical trials?
Yes. Dr. Jeffrey M. Crane has published 4 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Jeffrey M. Crane's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jeffrey M. Crane accept my insurance?
Dr. Jeffrey M. Crane accepts most major insurance plans, including Blue Cross Blue Shield. We recommend calling the office directly at 919-784-6818 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Crane isAdvanced. Learn about Breast Cancer.
- Lung AdenocarcinomaDr. Crane isAdvanced. Learn about Lung Adenocarcinoma.
- Paget Disease of the BreastDr. Crane isAdvanced. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Crane isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Crane isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Mountain SicknessDr. Crane isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Crane isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Crane isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Crane isExperienced. Learn about Anal Cancer.


